Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Rivastigmine
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[2] 5, 6 💬
2Rivastigmine capsule
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
3Rivastigmine CF
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
4Rivastigmine luye transdermal patch- 9.5MG/24H
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
5Rivastigmine patch 9.5 CM2
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
6Rivastigmine transdermal patch
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[2] 6, 13 💬
7Rivastigmine transdermal system
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
8Rivastigmine transdermal system 13.3 MG/24 H
(D02558)		[1] Rivastigmine[2] Rivastigmine tartrate (D02558),
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬